Displaying 231–240 of 285 research results
Feb 12, 2015
CME — What It Is, and Why People with Retinal Diseases Should Know About It
Dr. Gerald Fishman discusses cystoid macular edema (CME), a potentially damaging accumulation of fluid in the retina affecting up to 32 percent of people with retinitis pigmentosa (RP).
Feb 3, 2015
A Stem-Cells Video for Kids (and Newbies of All Ages)
Biology and genetics can be difficult to understand for even an educated adult, so when something kid-friendly is produced, especially a video, we are eager to share it.
Oct 29, 2014
Low-Hanging Fruit: Repurposing Drugs to Treat Retinal Diseases
Because repurposing relies on prior research and clinical data, it reduces the cost and time needed to establish a new therapeutic application for the drug.
Oct 10, 2014
Genetics 101: How Some Retinal Diseases are Inherited
To understand heredity, you have to know a little about genetics. Below is a review of the three major genetic-disease inheritance patterns.
Sep 8, 2014
Fascinating Facts About Retinal Cells
The retina is like a multi-layer cake, with each layer comprised of different types of cells, all playing important roles in retinal health and vision.
Aug 7, 2014
Inspired by Progress in Usher Syndrome Research
Mark Pennesi, M.D., Ph.D., a Foundation-funded clinical researcher at the Casey Eye Institute, discusses the first human study of gene therapy for Usher syndrome type 1B.
Aug 1, 2014
How Evolution is Leading to Gene Therapies for More Retinal Diseases
An innovative genetic-engineering approach called “directed evolution” to find optimal gene-delivery systems based on adeno-associated viruses (AAVs).
Jul 18, 2014
Despite Blindness, the Peaches are Sweet in Paran
The story of vision loss in a Peruvian village
Jun 21, 2014
VISIONS 2014 — The Multi-Talented Dr. Shannon Boye
Dr. Boye and her research team received a $900,000 grant for a gene therapy project targeting Leber congenital amaurosis.
Jun 21, 2014
VISIONS 2014 — My Retina Tracker: Track Your Vision and Drive the Research
The powerful and secure system enables patients to keep track of their clinical care and vision changes. At the same time, it enables scientists to search the “de-identified” (i.e., anonymous) patient information to study conditions and identify targets for treatments, preventions and cures.